These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 12663593)

  • 21. Incidence of non-severe hypoglycaemia and intensity of treatment among veterans with type 2 diabetes in the U.S.A.: a prospective observational study.
    Wendel CS; Fotieo GG; Shah JH; Felicetta J; Curtis BH; Murata GH
    Diabet Med; 2014 Dec; 31(12):1524-31. PubMed ID: 24975871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.
    Roumie CL; Min JY; Greevy RA; Grijalva CG; Hung AM; Liu X; Elasy T; Griffin MR
    CMAJ; 2016 Apr; 188(6):E104-E112. PubMed ID: 26811361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England.
    Farmer AJ; Brockbank KJ; Keech ML; England EJ; Deakin CD
    Diabet Med; 2012 Nov; 29(11):1447-50. PubMed ID: 22435781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland.
    Brändle M; Azoulay M; Greiner RA
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):217-30. PubMed ID: 21329624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin.
    Marvin MR; Inzucchi SE; Besterman BJ
    Diabetes Technol Ther; 2013 Mar; 15(3):246-52. PubMed ID: 23289409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HYPOGLYCEMIA IN THE ELDERLY WITH DIABETES: A GROWING PROBLEM WITH EMERGING SOLUTIONS.
    Grajower MM
    Endocr Pract; 2018 Mar; 24(3):312-314. PubMed ID: 29547043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia.
    ter Braak EW; Appelman AM; van de Laak M; Stolk RP; van Haeften TW; Erkelens DW
    Diabetes Care; 2000 Oct; 23(10):1467-71. PubMed ID: 11023138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study.
    Emral R; Tetiker T; Sahin I; Sari R; Kaya A; Yetkin İ; Cil SU; Tütüncü NB;
    BMC Endocr Disord; 2018 Feb; 18(1):9. PubMed ID: 29433560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
    Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
    J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1).
    Riddle MC; Bolli GB; Ziemen M; Muehlen-Bartmer I; Bizet F; Home PD;
    Diabetes Care; 2014 Oct; 37(10):2755-62. PubMed ID: 25078900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the Incidence and Risk Factors Associated With Mild and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes.
    Chantzaras A; Yfantopoulos J
    Value Health Reg Issues; 2022 Jul; 30():9-17. PubMed ID: 35033801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
    Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
    Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia.
    Davis TME; Dwyer P; England M; Fegan PG; Davis WA
    Diabetes Technol Ther; 2020 May; 22(5):367-373. PubMed ID: 31724878
    [No Abstract]   [Full Text] [Related]  

  • 36. Patients with diabetes requiring emergency department care for hypoglycaemia: characteristics and long-term outcomes determined from multiple data sources.
    Rajendran R; Hodgkinson D; Rayman G
    Postgrad Med J; 2015 Feb; 91(1072):65-71. PubMed ID: 25595126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes.
    Murata GH; Duckworth WC; Shah JH; Wendel CS; Mohler MJ; Hoffman RM
    J Diabetes Complications; 2005; 19(1):10-7. PubMed ID: 15642485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between hypoglycemia and the type of insulin in diabetic patients treated with multiple injections: an observational study.
    Wróbel MP; Wystrychowski G; Psurek A; Szymborska-Kajanek A; Strojek K
    Pol Arch Med Wewn; 2014; 124(4):173-9. PubMed ID: 24727596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey on hypoglycemia among insulin-treated patients with diabetes: The Colombian International Operations Hypoglycemia Assessment Tool population.
    Gómez AM; Chica LG; Burbano ÁF; Vásquez EM; Escobar JA; Arias PM; Molina DI
    Biomedica; 2019 Sep; 39(3):576-586. PubMed ID: 31584770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study.
    Fadini GP; Feher M; Hansen TK; de Valk HW; Koefoed MM; Wolden M; Zimmermann E; Jendle J
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5977-5990. PubMed ID: 31397845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.